The components of tumor microenvironment as biomarker for immunotherapy in metastatic renal cell carcinoma

Substantial improvement in prognosis among metastatic renal cell carcinoma (mRCC) patients has been achieved, owing to the rapid development and utilization of immunotherapy. In particular, immune checkpoint inhibitors (ICIs) have been considered the backbone of systemic therapy for patients with mR...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Jiaming, Zhou, Lu, Zhang, Zhe, Xiao, Xue, Qin, Yanning, Zhou, Xiaoying, Huang, Tingting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10282412/
https://www.ncbi.nlm.nih.gov/pubmed/37350955
http://dx.doi.org/10.3389/fimmu.2023.1146738

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10282412/
https://www.ncbi.nlm.nih.gov/pubmed/37350955
http://dx.doi.org/10.3389/fimmu.2023.1146738

Ejemplares similares